| Comprehensive Neurological Care Pa | |
|
18975 Collins Ave Sunny Isl Bch FL 33160-2300 | |
| (347) 634-9425 | |
| Not Available |
| Full Name | Comprehensive Neurological Care Pa |
|---|---|
| Speciality | Psychiatry & Neurology |
| Location | 18975 Collins Ave, Sunny Isl Bch, Florida |
| Authorized Official Name and Position | Julia Ostrovsky (MANAGER) |
| Authorized Official Contact | 3476349425 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Comprehensive Neurological Care Pa 18975 Collins Ave Unit 1602 Sunny Isles Beach FL 33160-2357 Ph: (347) 634-9425 | Comprehensive Neurological Care Pa 18975 Collins Ave Sunny Isl Bch FL 33160-2300 Ph: (347) 634-9425 |
| NPI Number | 1104406750 |
|---|---|
| Provider Enumeration Date | 04/08/2021 |
| Last Update Date | 03/26/2024 |
| Certification Date | 03/26/2024 |
| Medicare PECOS PAC ID | 0446651210 |
|---|---|
| Medicare Enrollment ID | O20210630002686 |
News Archive
New research indicates that Mexican-Americans born in the United States who are aged 55 and over are significantly more likely than Mexican-American immigrants to report that they have substantial limitations in one or more basic physical activities such as walking, climbing stairs, reaching, lifting, or carrying. (30% versus 25%).
Recruitment of leukocytes is a hallmark of stent thrombosis, according to results from the PRESTIGE study presented today at ESC Congress and published in European Heart Journal. The findings suggest that immune cell mediated thrombotic processes may be a realistic target for novel therapies to prevent stent thrombosis.
Scientists at The New York Stem Cell Foundation Research Institute are one step closer to creating a viable cell replacement therapy for multiple sclerosis from a patient's own cells.
PamLab L.L.C., developer and marketer of Metanx®, announced today that the results of a study to determine if nutritional management with Metanx® improves numbness in the feet of patients with Diabetic Neuropathy (DN) was published in the fourth quarter 2010 issue of Reviews in Neurological Diseases. The study demonstrated that Metanx®, a medical food available by prescription, promotes restoration of lost cutaneous sensation in DN patients.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104406750 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | (* (Not Available)) | Primary |
| Provider Name | Nina Tsakadze |
|---|---|
| Provider Type | Practitioner - Neurology |
| Provider Identifiers | NPI Number: 1356534135 PECOS PAC ID: 4587835095 Enrollment ID: I20110913000836 |
News Archive
New research indicates that Mexican-Americans born in the United States who are aged 55 and over are significantly more likely than Mexican-American immigrants to report that they have substantial limitations in one or more basic physical activities such as walking, climbing stairs, reaching, lifting, or carrying. (30% versus 25%).
Recruitment of leukocytes is a hallmark of stent thrombosis, according to results from the PRESTIGE study presented today at ESC Congress and published in European Heart Journal. The findings suggest that immune cell mediated thrombotic processes may be a realistic target for novel therapies to prevent stent thrombosis.
Scientists at The New York Stem Cell Foundation Research Institute are one step closer to creating a viable cell replacement therapy for multiple sclerosis from a patient's own cells.
PamLab L.L.C., developer and marketer of Metanx®, announced today that the results of a study to determine if nutritional management with Metanx® improves numbness in the feet of patients with Diabetic Neuropathy (DN) was published in the fourth quarter 2010 issue of Reviews in Neurological Diseases. The study demonstrated that Metanx®, a medical food available by prescription, promotes restoration of lost cutaneous sensation in DN patients.
› Verified 4 days ago
| Provider Name | Ellen I Edgar |
|---|---|
| Provider Type | Practitioner - Neurology |
| Provider Identifiers | NPI Number: 1326343625 PECOS PAC ID: 4486838885 Enrollment ID: I20210702000441 |
News Archive
New research indicates that Mexican-Americans born in the United States who are aged 55 and over are significantly more likely than Mexican-American immigrants to report that they have substantial limitations in one or more basic physical activities such as walking, climbing stairs, reaching, lifting, or carrying. (30% versus 25%).
Recruitment of leukocytes is a hallmark of stent thrombosis, according to results from the PRESTIGE study presented today at ESC Congress and published in European Heart Journal. The findings suggest that immune cell mediated thrombotic processes may be a realistic target for novel therapies to prevent stent thrombosis.
Scientists at The New York Stem Cell Foundation Research Institute are one step closer to creating a viable cell replacement therapy for multiple sclerosis from a patient's own cells.
PamLab L.L.C., developer and marketer of Metanx®, announced today that the results of a study to determine if nutritional management with Metanx® improves numbness in the feet of patients with Diabetic Neuropathy (DN) was published in the fourth quarter 2010 issue of Reviews in Neurological Diseases. The study demonstrated that Metanx®, a medical food available by prescription, promotes restoration of lost cutaneous sensation in DN patients.
› Verified 4 days ago
| Provider Name | Tamara Goodman |
|---|---|
| Provider Type | Practitioner - Neurology |
| Provider Identifiers | NPI Number: 1083094080 PECOS PAC ID: 1153668660 Enrollment ID: I20210702000844 |
News Archive
New research indicates that Mexican-Americans born in the United States who are aged 55 and over are significantly more likely than Mexican-American immigrants to report that they have substantial limitations in one or more basic physical activities such as walking, climbing stairs, reaching, lifting, or carrying. (30% versus 25%).
Recruitment of leukocytes is a hallmark of stent thrombosis, according to results from the PRESTIGE study presented today at ESC Congress and published in European Heart Journal. The findings suggest that immune cell mediated thrombotic processes may be a realistic target for novel therapies to prevent stent thrombosis.
Scientists at The New York Stem Cell Foundation Research Institute are one step closer to creating a viable cell replacement therapy for multiple sclerosis from a patient's own cells.
PamLab L.L.C., developer and marketer of Metanx®, announced today that the results of a study to determine if nutritional management with Metanx® improves numbness in the feet of patients with Diabetic Neuropathy (DN) was published in the fourth quarter 2010 issue of Reviews in Neurological Diseases. The study demonstrated that Metanx®, a medical food available by prescription, promotes restoration of lost cutaneous sensation in DN patients.
› Verified 4 days ago
News Archive
New research indicates that Mexican-Americans born in the United States who are aged 55 and over are significantly more likely than Mexican-American immigrants to report that they have substantial limitations in one or more basic physical activities such as walking, climbing stairs, reaching, lifting, or carrying. (30% versus 25%).
Recruitment of leukocytes is a hallmark of stent thrombosis, according to results from the PRESTIGE study presented today at ESC Congress and published in European Heart Journal. The findings suggest that immune cell mediated thrombotic processes may be a realistic target for novel therapies to prevent stent thrombosis.
Scientists at The New York Stem Cell Foundation Research Institute are one step closer to creating a viable cell replacement therapy for multiple sclerosis from a patient's own cells.
PamLab L.L.C., developer and marketer of Metanx®, announced today that the results of a study to determine if nutritional management with Metanx® improves numbness in the feet of patients with Diabetic Neuropathy (DN) was published in the fourth quarter 2010 issue of Reviews in Neurological Diseases. The study demonstrated that Metanx®, a medical food available by prescription, promotes restoration of lost cutaneous sensation in DN patients.
› Verified 4 days ago